Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 15, Issue 7, Pages 1448-1452
Publisher
Wiley
Online
2017-04-27
DOI
10.1111/jth.13716
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Von Willebrand Factor — A New Target for TTP Treatment?
- (2016) Agnès Veyradier NEW ENGLAND JOURNAL OF MEDICINE
- Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
- (2016) Flora Peyvandi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012
- (2016) Ruchika Goel et al. TRANSFUSION
- Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura
- (2015) Bowie Han et al. AMERICAN JOURNAL OF HEMATOLOGY
- Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality
- (2015) R. Goel et al. BLOOD
- How I treat refractory thrombotic thrombocytopenic purpura
- (2015) Farzana A. Sayani et al. BLOOD
- Comprehensive Care of Adults with Acute Ischemic Stroke
- (2015) Patricia A. Hughes Critical Care Nursing Clinics of North America
- The Global Burden of Ischemic Heart Disease in 1990 and 2010
- (2014) Andrew E. Moran et al. CIRCULATION
- Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center
- (2014) Y. Benhamou et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura
- (2013) C. C. Deford et al. BLOOD
- Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
- (2012) Marie Scully et al. BRITISH JOURNAL OF HAEMATOLOGY
- Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience
- (2012) Y. Benhamou et al. HAEMATOLOGICA
- Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab
- (2010) Jens Marcus Chemnitz et al. ANNALS OF HEMATOLOGY
- How I treat patients with thrombotic thrombocytopenic purpura: 2010
- (2010) J. N. George BLOOD
- Survival and relapse in patients with thrombotic thrombocytopenic purpura
- (2009) J. A. K. Hovinga et al. BLOOD
- Cognitive deficits after recovery from thrombotic thrombocytopenic purpura
- (2009) April S. Kennedy et al. TRANSFUSION
- Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura
- (2008) J. E. Sadler BLOOD
- Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura
- (2008) Qurana F. Lewis et al. TRANSFUSION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search